Back
Protalix BioTherapeutics Stock Price Chart

Marketing's AI Disruption Is Now Secure Your Stake Today!
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
Sell
50
PLX
Protalix BioTherapeutics
Last Price:
$2.59
Seasonality Move:
3.22%
7 Day Trial
ALL ACCESS PASS
$
7

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai.
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PLX is experiencing slight selling pressure.
Protalix BioTherapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.55 | Sell |
20-day SMA: | 2.4 | Buy |
50-day SMA: | 2.43 | Buy |
200-day SMA: | 1.57 | Buy |
8-day EMA: | 2.52 | Buy |
20-day EMA: | 2.46 | Buy |
50-day EMA: | 2.34 | Buy |
200-day EMA: | 1.82 | Buy |
Protalix BioTherapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 56.67 | Buy |
Chaikin Money Flow: | -26642 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.27 - 2.51) | Buy |
Bollinger Bands (100): | (1.64 - 2.5) | Buy |
Protalix BioTherapeutics Technical Analysis
Mar 19 | Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
19 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Protalix BioTherapeutics Stock
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.54 while PLX 8-day simple moving average is 2.55, which is a Sell signal.
-
The stock price of PLX is 2.54 while Protalix BioTherapeutics 20-day SMA is 2.40, which makes it a Buy.
-
Protalix BioTherapeutics 50-day simple moving average is 2.43 while PLX share price is 2.54, making it a Buy technically.
-
PLX stock price is 2.54 and Protalix BioTherapeutics 200-day simple moving average is 1.57, creating a Buy signal.
PLX Technical Analysis vs Fundamental Analysis
Sell
50
Protalix BioTherapeutics (PLX)
is a Sell
Is Protalix BioTherapeutics a Buy or a Sell?
-
Protalix BioTherapeutics stock is rated a SellThe current Protalix BioTherapeutics [PLX] share price is $2.54. The Score for PLX is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Protalix BioTherapeutics Stock Info
Market Cap:
198.2M
Price in USD:
2.54
Share Volume:
452.9K
Protalix BioTherapeutics 52-Week Range
52-Week High:
2.76
52-Week Low:
0.82
Sell
50
Protalix BioTherapeutics (PLX)
is a Sell
Protalix BioTherapeutics Share Price Forecast
-
What is the Protalix BioTherapeutics stock price today?The Protalix BioTherapeutics stock price is 2.54 USD today.
-
Will PLX stock go up or go down?Protalix BioTherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Protalix BioTherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Protalix BioTherapeutics is overvalued.
Is Protalix BioTherapeutics Stock a Buy?
-
Protalix BioTherapeutics share price is 2.54 while PLX 8-day exponential moving average is 2.52, which is a Buy signal.
-
The stock price of PLX is 2.54 while Protalix BioTherapeutics 20-day EMA is 2.46, which makes it a Buy.
-
Protalix BioTherapeutics 50-day exponential moving average is 2.34 while PLX share price is 2.54, making it a Buy technically.
-
PLX stock price is 2.54 and Protalix BioTherapeutics 200-day simple moving average is 1.82, creating a Buy signal.
Technical Analysis of Protalix BioTherapeutics
Should I short Protalix BioTherapeutics stock?
-
PLX Moving Average Covergence Divergence (MACD) indicator is 0.05, suggesting Protalix BioTherapeutics is a Buy
-
Protalix BioTherapeutics Relative Strength Index (RSI) is 56.67, which suggest Protalix BioTherapeutics is overbought
-
The Bollinger Bands (25) for Protalix BioTherapeutics is (2.27 - 2.51), which suggest Protalix BioTherapeutics is a Buy
-
The Bollinger Bands (100) for Protalix BioTherapeutics is (1.64 - 2.5), which suggest Protalix BioTherapeutics is a Buy
* Protalix BioTherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.